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research articles.
Over the last decade a shift in management of rheu-
matoid arthritis (RA) from inpatient to outpatient mul-
tidisciplinary care is noticeable. Innovations relating to
the nursing practice and care for chronic patients have
been implemented to produce new forms of health
care such as the clinical nurse specialist.
Chapter 1 is an introduction in which the relevance of
the research is described. Rheumatoid Arthritis (RA)
is a systemic illness with chronic, symmetric poly-
arthritis as its most characteristic clinical feature. The
care approach of the patient with RA is diverse, com-
plex, and varies within and between patients depend-
ing on disease activity and functional status. Beside
intensive treatment by a rheumatologist and other
medical specialists, optimal longitudinal treatment
requires coordinated care and the expertise of a num-
ber of health professionals. Multidisciplinary care can
be provided in various ways. A multidisciplinary team
for patients with RA usually consists of a rheumatol-
ogist, a nurse, physical therapist, occupational thera-
pist and social worker. Multidisciplinary team care
programmes can be executed during admission in a
hospital or rehabilitation clinic (inpatient care) or on an
outpatient basis in the same setting. Because there
are limitations regarding the organisation and availa-
bility of multidisciplinary team services for large num-
bers of patients and constraints on health care
expenditures, new forms of health care are needed
such as the clinical nurse specialist. Clinical nurse
specialists provide education, guidance and clinical
care, which is added to the regular care provided by
the rheumatologists. Although the introduction of nurse
specialists becomes more common in the manage-
ment of RA, the investigation on effectiveness is
limited.
The continuing development of new treatment stra-
tegies for patients with RA and the increasing scarcity
of resources make it necessary to prove that treatment
strategies are not only effective, but that they are also
cost-effective. One method of economic evaluation is
cost-utility analysis of which the standard gamble
(SG), the time trade-off (TTO) and the rating scale
(RS) or visual analogue scale (VAS) are the most
widely used methods. However, there are no studies
in which the feasibility, the reliability, and the validity
of the TTO have been described in patients with RA.
Chapter 2 describes the value of the time trade off
method measuring utilities in patients with RA. To
measure the effect of intervention, several utility meas-
urements can be used such as the standard gamble
(SG), the time-trade off (TTO), and the visual ana-
logue scale (RS). In this chapter the feasibility, the
reliability, and the validity of the TTO and the VAS in
patients with RA are described. The TTO appeared to
be good and reliable in a group of patients with RA.
The TTO scores were generally higher than the RS
scores. TTO was poorly to moderate correlated to
measures of Quality of Life (QoL), functional ability,
and disease activity suggesting that other factors may
play a role. These instruments may therefore not
entirely appraise the effect of intervention and further
research regarding the usefulness of the instruments
in cost effectiveness studies are necessary.
Chapter 3 describes the validity of the Rheumatoid
Arthritis Quality of Life (RAQol) questionnaire. The
RAQoL is a disease specific instrument to measure
the Quality of Life of patients with RA. The RAQoL was
applied in a group of patients with increasing difficulty
in performing activities of daily living and in a group of
patients with stable RA. Moderate to high correlations
were found between the RAQoL and measures of util-
ity and QoL. The RAQoL was found to be valid in dif-
ferent populations of patients with RA and is a
valuable instrument in cost effectiveness studies. Fur-
thermore the instrument includes questions regarding
physical contact, a dimension not covered by other
instruments but an important item for patients with RA.
Chapter 4 reports the short-term results of a random-
ised comparison of care provided by a clinical nurse
specialist, inpatient team care and day patient team
care in RA. In a chronic disease such as RA, disease
management delivery of coordinated care by a team
of health professionals who communicate with each
other on a regular basis is generally assumed to be
an optimal strategy. Another form of care is the intro-
duction of the clinical nurse specialist. Apart from actu-
ally delivering clinical care, education and assistance,
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by other health professionals as well. After one year
all patients had improved according to functional sta-
tus, quality of life, health utility and disease activity.
Patients who were treated according to the multidis-
ciplinary care were more satisfied than patients who
received nurse specialist care. No difference, except
for the improvement in functional status, was found
between inpatient and outpatient multidisciplinary
care. The authors concluded that care provided by the
clinical nurse specialist is a useful addition to other
existing care. An interesting observation in this study
was that with increasing age, the advantage of any
type of care over the others switches from clinical
nurse specialist and inpatient care to day care patient
team.
Chapter 5 reports the long-term effectiveness of the
three different types of care as described in Chapter 4.
Most of the first year results were sustained for two
years. Patients in the clinical nurse specialist group
received less home care than inpatients and attended
the clinical nurse specialist more frequently, but no
other differences in utilisation rates were found during
the follow-up period after the intervention.
Chapter 6 describes the costs and effects over two
years of the three intervention groups as described in
Chapter 5. Costs were calculated from a societal point
of view and comprised both direct and indirect costs.
The initial intervention costs were significantly different
and were 7200, 75,000, and 74,100, respectively.
Other healthcare costs and non-healthcare costs did
not differ significantly over the two years. Also the
observed QALY’s did not differ over two years. From
a health-economic perspective, care provided by the
clinical nurse specialist seems to be the most cost
effective care.
Chapter 7 describes the validation of a novel satisfac-
tion questionnaire for patients with RA receiving out-
patient clinical nurse specialist care, inpatient day care
or day patient team care. The satisfaction question-
naire comprises 8 domains: waiting time, autonomy,
continuity, efficiency, effectiveness, knowledge, infor-
mation and empathy. In addition, three domains per-
taining to organisational differences among the three
types of care were added: co-ordination among health
professionals, office environment and non-financial
access. This instrument seemed to be a useful instru-
ment for measuring satisfaction with different forms of
multidisciplinary care in patients with RA. Patients
were more satisfied with care provided by an inpatient
or a day care patient multidisciplinary team than with
care by a clinical nurse specialist especially due to the
objective organisational differences between the three
forms of care.
In Chapter 8, the utility and the effectiveness of the
Futuro wrist orthosis is compared with the synthetic
orthosis of ThermoLyn.
The last chapter in this thesis addresses the implica-
tions and recommendations for further research.
Because health care budgets are becoming more lim-
ited in the Netherlands, the author conclude that, from
a health economic perspective, care provided by the
clinical nurse specialist is the preferred form of treat-
ment although the results regarding satisfaction have
to be improved. Thus, the introduction of a clinical
nurse specialist could be a very promising form of care
for all outpatient clinics of rheumatology and could
also be applied as care for other chronic diseases.
Although the type of care provided by the clinical nurse
specialist differs, this care has also been introduced in
other countries. However, the multidisciplinary team
care facilities are still needed for patients with severe
disease activity or in whom care by the clinical nurse
specialist has failed. The choice of care is dependent
on factors such as availability of care, the patient’s and
physician’s preferences for specific care, and health
care budgets.
Overall, this is an interesting thesis with respect to
effects and costs of multidisciplinary care and nurse
specialist care in RA. The observed results are a first
step towards further research for application and com-
parison of different forms of care in other settings and
among groups of patients with a variety of disease
severity. Furthermore, the thesis highlights the prob-
lems concerning the use of outcome measures such
as the TTO and the RAQoL to measure effectiveness
of treatments in economic analyses. This is an impor-
tant issue because development of new treatment
strategies for patients with RA makes it necessary to
prove that they are both effective and cost effective.
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